Table 2 PSA at time of commencement for ADT for Relapse
From: Long-term outcomes of SBRT for PSMA PET detected oligometastatic prostate cancer
Characteristic | N = 511 |
|---|---|
PSA* | 5 (2, 9) |
Groups | |
<2 | 12 (24%) |
2–5 | 15 (29%) |
5–10 | 12 (24%) |
10+ | 12 (24%) |
From: Long-term outcomes of SBRT for PSMA PET detected oligometastatic prostate cancer
Characteristic | N = 511 |
|---|---|
PSA* | 5 (2, 9) |
Groups | |
<2 | 12 (24%) |
2–5 | 15 (29%) |
5–10 | 12 (24%) |
10+ | 12 (24%) |